hotspot -WSS

hotspot

author：fashion 2025-09-29 13:33:58 Page View：41859

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 4th of July breaks record for highest global temperature ever measured
Next article： Psychedelics group wrestles with new pharma identity

explore

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

The FDA must approve intranasal treatments for anaphylaxis

AdobeMysonThomashascarriedaroundaneedlesinceheenteredkindergartenattheageof5.Thatwasabigresponsibili

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

Pfizer's Covid pill remains 89% effective in final analysis, company says

Paxlovid,Pfizer'spilltotreatCovid-19PfizerPaxlovid,Pfizer’spilltotreatCovid-19,retainedits89%efficac

hotspot

comprehensive

explore

Pfizer's Covid pill remains 89% effective in final analysis, company says